Article Sidebar

PDF
Published: 2020-09-15
Abstract Views: 187
Views PDF: 220
DOI: https://doi.org/10.53747/jnst.v10i3.6
Issue
Vol. 10 No. 3 (2020)
Section
Articles
How to Cite
Thai, H. H., Dat, N. T., Anh, N. T. V., Lam, P. H., Linh, B. D., Duc, L. M., & Trung, . P. Q. (2020). Comparison and evaluation for the dose distribution and physical characteristics between two AAA and AXB algorithms in Eclipse v13.6 software on treatment plans in regions heterogenous densities at 108 Military Central Hospital. Nuclear Science and Technology, 10(3), 31-40. https://doi.org/10.53747/jnst.v10i3.6

Comparison and evaluation for the dose distribution and physical characteristics between two AAA and AXB algorithms in Eclipse v13.6 software on treatment plans in regions heterogenous densities at 108 Military Central Hospital

Hoang Huu Thai1, Nguyen Tien Dat1, Nguyen Thi Van Anh2, Pham Hong Lam3, Bui Duy Linh4, Le Manh Duc2, Pham Quang Trung2
1 Hanoi University of Sciences and Technology, N°1 Dai Co Viet, Hai Ba Trung, Hanoi, Vietnam
2 Radiation Oncology and Radiosurgery Department, 108 Military Central Hospital, N° 1 Tran Hung Dao, Hai Ba Trung, Hanoi, Vietnam
3 Oncology Center, 103 Military Hospital, N° 261 Phung Hung, Phuc La, Ha Dong, Hanoi, Vietnam
4 Institute for Nuclear Science and Technology, N° 179 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi, Vietnam.

Main Article Content

Abstract

The aim of this study is to compare and evaluate the dose distribution and physical characteristics of two algorithms Anisotropic Analytical Algorithm (AAA) and Acuros XB (AXB) inEclipse v13.6 software in regions heterogeneous densities. Computed Tomography Simulation (CT –Sim) data of 48 treated cancer patients (20 head and neck cancer (H&N) patients, 15 esophageal cancer patients, 8 lung cancer patients with 3 Dimensions Conformal Radiation Therapy (3D-CRT)and 5 lung cancer patients treated with Volumetric Modulated Arc Therapy (VMAT)) were used to replan the Eclipse v13.6 software with two algorithm AAA and AXB. For all plans, the Quality of Coverage (Q), the Conformity Index (CI), the Homogeneity Index (HI) and the dose volume histograms (DVH) for the targets and the organs at risk (OARs) were compared and evaluated. Pretreatment quality assurance (QA) was performed using the Electronic Portal Imaging Device(EPID) for all VMAT plans, and the gamma index method was used to qualify the agreement between calculations and measurements. In addition, total Monitor Units (MUs) and the calculation time were investigated. The indicators obtained from the H&N VMAT plans calculated by AAA close to ideal values than AXB. The total MUs obtained from two algorithms are approximately equal. The lung cancer 3D – CRT plans, the indicators for target and OARs are approximately the same. However, the calculation time of the AAA is faster than the AXB from 7.5 to 14 times. The indicator obtained from the lung cancer VMAT plans calculated by two algorithms AAA and AXB are approximately equal. The total MUs and time calculation are approximate the same. However, the V5, V10, V20 and Mean Lung Dose (MLD) obtained from AAA is lower than AXB. For esophageal cancer VMAT plans, the indicators HIRTOG, HIWu, and Q calculated by AAA close to the ideal values than AXB. However, the indicators CIPaddick, CIICRU-62, V5, V10, V20 and MLD calculated by AXB are better than AAA. The dose distribution indicators obtained from AAA algorithm are better than AXB algorithm in H&N cancer and lung cancer plans. For the esophageal cancer plans, AXB algorithm gave the dose distribution indicator are better than AAA.

Article Details

Keywords

AAA, AXB, Conformity Index, Homogeneity Index, H&N cancer, Lung cancer, Esophageal cancer, Eclipse v13.6.

References

[1]. A. C. Herrick, “A comparative dosimetric analysis of the effect of heterogeneity corrections used in three treatment planning algorithms,” Med. Univ. Ohio, vol. 51, no. 1, pp. 9-10, 2010.
[2]. G. A. Failla, T. Wareing, Y. Archambault, and S. Thompson, “Acuros® XB Advanced dose calculation for the EclipseTM treatment planning system. Clinical Perspectives,” Palo Alto, CA Varian Med. Syst., pp. 1-2, 2010.
[3]. M. L. Shaw E, Kline R, Gillin M, Souhami L, Hirschfeld A, Dinapoi R, “Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines,” Int J Radiat. Oncol. Biol. Phys, vol. 27, pp. 1231–1239, 1993.
[4]. D. Zentralbibliothek, “ICRU Report 62, ”International Commission on Radiation Units and Measurements, no. February. 2018.
[5]. Paddick I, “A simple scoring ratio to index the conformity of radiosurgical treatment plans,” J. Neurosurg., vol. 93, no. Suppl 3, pp. 219–222, 2000.
[6]. Wu Q, Mohan R, “Algorithms and functionality of an intensity modulated radiotherapy optimization system,” Med Phys, no. 27, pp. 701–711, 2000.
[7]. R. Lilenbaum, R. Komaki et al., “Radiation Therapy Oncology Group Rtog 0623 a Phase Ii Trial of Combined Modality Therapy with Growth Factor,” Radiation Ther. Oncol. Gr., pp. 1-46, 2008.
[8]. N. Lee, A. Kramer et al., “A phase II study of intensity modulated radiation therapy (IMRT) - Chemotherapy for nasopharyngeal cancer,” Radiation Ther. Oncol. Gr. (RTOG 0225), pp. 1-47, 2005.
[9]. C. Drug, P. Nsc, E. Sherman et al., “RTOG 0912 Protocol: A randomized phase II study of concurrent Intensity Modulated Radiation Therapy (IMRT), paclitaxel and pazopanib (Nsc 737754)/placebo, for the treatment of anaplastic thyroid cancer,” Radiation Ther. Oncol. Gr., no. Nsc 737754, pp. 1-95, 2010.
[10]. N. Lee and J. Kim, “RTOG 0615 Protocol: Radiation Therapy Oncology Group Rtog 0615,” Radiation Ther. Oncol. Gr., pp 1-78, 2008.
[11]. W. S. Rh, “Eclipse Algorithms Reference Guide Eclipse,” Distribution, no. April, pp. 1–350, 2010.
[12]. L. Wang, E. Yorke, G. Desobry, and C.-S. Chui, “Dosimetric advantage of using 6 MV over 15 MV photons in conformal therapy of lung cancer: Monte Carlo studies in patient geometries,” J. Appl. Clin. Med. Phys., vol. 3,no. 1, pp. 51–59, 2007.
[13]. J. Mazurier, “Dose calculation algorithm,”Phys. Medica, vol. 29, p. e19, 2013.
[14]. W.-Z. Chen, “Impact of dose calculation algorithm on radiation therapy,” World J. Radiol., vol. 6, no. 11, p. 874, 2014.
[15]. Y. L. Woon, S. P. Heng, J. H. D. Wong, and N. M. Ung, “Comparison of selected dose calculation algorithms in radiotherapy treatment planning for tissues with inhomogeneities,” J. Phys. Conf. Ser., vol. 694, no. 1, pp. 1-5, 2016.
[16]. L. B. Marks et al., “Radiation Dose–Volume Effects in the Lung,” Int. J. Radiat. Oncol., vol. 76, no. 3, pp. S70–S76, 2010.
[17]. P. Y. R. Gangarapu Sri Krishna, Vuppu Srinivas, “Clinical implications of Eclipse analytical anisotropic algorithm and Acuros XB algorithm for the treatment of lung cancer,” J Med Phys, no. 1, pp. 219–223, 2016.